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Abstract
Ankle arthritis is a useful clinical signpost to differential diagnosis in rheumatic disease. Biomechanical
features and differences in cartilage physiology compared with the knee may confer protection of the
ankle joint from factors predisposing to certain arthritides. The prevalence of ankle OA is low, and usu-
ally secondary to trauma. Primary OA of the ankle should be investigated for underlying causes, espe-
cially haemochromatosis. New presentations of inflammatory mono/oligo arthritis involving the ankle
are more likely due to undifferentiated arthritis or spondyloarthritis than RA, and gout over CPPD. The
ankle is often involved in bacterial and viral causes of septic arthritis, especially bacterial, chikungunya
and HIV infection, but rarely tuberculosis. Periarticular hind foot swelling can be confused with ankle
arthritis, exemplified by Lofgren’s syndrome and hypertrophic osteoarthropathy where swelling is due
to subcutaneous oedema and osteitis respectively, and the ankle joint is rarely involved.
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Introduction
Despite recent major advances in management of
rheumatic diseases, clinical diagnosis can remain chal-
lenging. Pattern recognition is an important part of this
process, encompassing all aspects of the patient, his-
tory, examination and results of investigations.
Assessment of the individual joints affected is particular-
ly important in formulating a differential diagnosis, with,
for example, characteristic involvement of the DIP and
first carpo-metacarpal joints in OA, whereas these joints
are generally spared in RA.
This review article focuses on the ankle joint across
the spectrum of rheumatic conditions, where it is differ-
entially affected in certain arthritides and spared in
others. In this regard, the ankle is an interesting and
perhaps neglected signpost in the process of differential
diagnosis. We also draw attention to peri-articular
mimics of ankle arthritis, as the hind foot is a complex
region requiring careful clinical examination to assess
the cause of pain and swelling.
Ankle joint anatomy
Evolutionary considerations
The ankle joint is a complex structure comprised of a
diarthrosis between the tibia and talus (talocrural) and
an interosseous syndesmosis between the tibia and fib-
ula [1]. Stability is provided by the medial (deltoid) and
lateral collateral ligaments, with movements occurring
predominantly as a hinge providing dorsi-plantar flexion
with additional rotation and inversion/eversion [1].
Rheumatology key messages
. Primary OA of the ankle is rare and should prompt screening for haemochromatosis.
. Incident inflammatory arthritis involving the ankle is more likely due to SpA than RA.
. In Lofgren’s syndrome, hind foot swelling is due to periarticular oedema rather than ankle arthritis.
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Compared with the hip and knee, the range of move-
ment of the ankle while walking is relatively small, max-
imum 30

, increasing to 56

when descending stairs [1].
Development of the ankle joint in homo sapiens
occurred after the knee by many thousand years. Knee
(proximal tibia) specimens dating 2 million years ago are
the same morphologically as in homo sapiens, acknowl-
edged to have evolved 300 000 years ago. In contrast,
the morphology of the ankle (distal tibia) in specimens
dating 1.6 million years ago is primitive compared with
the evolved homo sapiens ankle [2]. While this is a strik-
ing evolutionary difference, the consequences in terms
of susceptibility to arthritis are not established.
Cartilage differences compared with knee
Ankle (talar dome) cartilage is distinctive in being denser
and stiffer than knee cartilage, due to higher proteogly-
can and sulphated glycosaminoglycan content, lower
water content and hydraulic permeability [3, 4].
Differences in partition coefficient support the hypoth-
esis that differences in transport properties of ankle and
knee cartilage may explain differences in the incidence
of OA between these joints [3, 4]. Furthermore, ankle
chondrocytes are eight times less responsive than knee
chondrocytes to the inhibitory effect of interleukin-1 on
proteoglycan synthesis, and (unlike knee chondrocytes)
resistant to the depleting effects of fibronectin fragments
on proteoglycan, meaning less susceptibility to matrix
loss in a proinflammatory state [4].
Osteoarthritis
Palaeopathology studies of human skeletal remains from
archaeological sites generally find no evidence of ankle
OA, or a very low prevalence <8% [5]. Contemporary
series report that while 15% of the world’s population
are affected by symptomatic OA of any joint, 6–10% by
symptomatic knee OA, only 1–4.4% are affected by
ankle OA [4, 6–8].
The ankle differs from the hip and knee in terms of
aetiology of OA. A primary aetiology, i.e. arising in the
absence of trauma or adverse biomechanical factors,
accounts for most cases of hip and knee OA (65% and
82% respectively) with trauma a much less frequent
cause, attributed to 8% and 12.5%, respectively [9]. In
contrast, the aetiology of ankle OA is much more fre-
quently due to trauma, reported in 70% and 78% of
cases in two orthopaedic series, compared with a pri-
mary aetiology in just 7.2% and 9% [8, 9]. Thus, the
ankle seems protected from primary OA, in contrast to
the hip and knee.
The very low prevalence of primary OA of the ankle is
surprising given the forces transmitted through the ankle
are 5 to 13  body weight during activities such as run-
ning, and much greater than through the hip and knee
[1, 10]. Protective factors, compared with the hip or
knee, may include (i) a relatively high level of congru-
ency, with most load applied to the talar dome, (ii) a
large load bearing area, (iii) a narrow range of motion
through everyday activities and (iv) greater resilience of
ankle cartilage due to differences in density, stiffness,
water content and permeability [4]. Whether the evolu-
tionary delay in development of the ankle in homo sapi-
ens permitted these advantageous characteristics is
uncertain.
When OA of the ankle is reported to be secondary to
a preceding arthritis, the conditions listed in a series of
390 patients with symptomatic end stage disease were
RA, haemochromatosis, haemophilia, avascular necrosis
of the talus and post infectious arthritis [8]. Among
patients with genetic haemochromatosis (GH) an
arthropathy resembling accelerated OA, with florid radio-
graphic features, is well described [11]. Ankle arthrop-
athy was found in 32–61% of GH patients attending
secondary care centres and reported by 35% of GH
patients responding to a questionnaire [12, 13]. A link
between primary OA of the ankle, MCP 2/3 joint OA and
the lesser H63D mutation in the high iron HFE gene has
also been described [14]. MRI of the ankle of GH
patients with arthropathy reveals more severe appearan-
ces compared with paired primary OA controls, with sig-
nificantly higher scores for bone marrow lesion/cyst size
and number, presence and extent of full thickness cartil-
age loss and osteophytes [15]. Imaging examples of
haemochromatosis arthropathy of the ankle are shown
in Fig 1.
Recurrent haemarthroses cause the arthropathy seen
in haemophilia, with joint destruction as a consequence.
Characteristically weight bearing lower limb large joints
are affected, suggesting an aetiologic combination of
mechanical factors as well as the intrinsic clotting dis-
order, leading to specific joint bleeds. In haemophilia the
ankle, as well as the knees and elbows, is a frequently
involved joint [16] and in one series the most commonly
affected joint [17].
Incident inflammatory arthritis
Monoarthritis (excluding crystal and septic causes)
In a Norwegian series of 347 patients with incident
monoarthritis of <16 weeks duration and followed for
2 years [18], the ankle was involved in 16.7%, the se-
cond most commonly involved joint after the knee
(49.3%). The outcome of ankle monoarthritis was reso-
lution, degenerative disease or gout in 89.7% of cases,
with 10.3% progressing to a chronic inflammatory
rheumatic disease, either chronic spondyloarthritis (SpA)
or undifferentiated arthritis (UA) and no cases develop-
ing RA or psoriatic arthritis (PsA). On multivariate ana-
lysis the odds ratio for developing any chronic
inflammatory arthritis was 0.5 (0.2–1.2) for the ankle and
2.0 (1.0–4.2) for the wrist, compared with all other joints.
In a Korean series of 171 patients with monoarthritis,
the ankle was the affected joint in 18.7%, the third most
commonly involved joint after the knee (24%) and wrist
(22.8%). Progressive ankle monoarthritis occurred in
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20/32 cases (62.5%) and multi variate analysis showed
ankle monoarthritis to predict a final diagnosis of periph-
eral SpA, odds ratio 3.04, 1.13–8.19 [19]. In a French
series of 50 patients presenting with <1 year of monoar-
thritis (excluding septic and crystal arthritis), the ankle
was involved in 5 cases (10%) with 2 recovering fully, 2
developing SpA and 1 developing RA [20]. In a UK ser-
ies of 25 cases of incident ankle monoarthritis, the initial
diagnosis was UA in 48%, sarcoid 24% and SpA 12%.
Persistent disease developed in 8 cases (32%), with 3
sarcoid, 2 RA, 1 SLE, 1 SpA and I UA [21].
Thus, the ankle, in these combined series of 593
patients presenting with a monoarthritis, is reported to
be the affected joint in 10–18.7% of all cases. The out-
come is reported to be resolution in many cases, pos-
sibly exaggerated if the initial diagnosis was not ankle
arthritis but another cause of hind foot swelling such as
traumatic tendon or ligament injury. In those with a per-
sisting arthropathy the diagnostic pattern appears more
likely to be SpA/UA or sarcoidosis. This is in contrast to
RA; in a study of 102 patients with early RA of <1 year
duration, ankle monoarthritis was the initial presentation
in only 6% [22].
Oligo/polyarthritis
In a UK series of 324 cases of early inflammatory oli-
goarthritis of <3 months duration [21], the ankle was
involved in 78 cases (24%). Bilateral ankle disease in-
dependently associated with acute sarcoid arthritis and
unilateral ankle involvement was associated with a sub-
sequent diagnosis of SpA. In those with an oligoarthritis
and negative for RF and ACPA, ankle involvement was
also associated with a diagnosis of sarcoid, SpA and
UA. As in incident monoarthritis, a lack of association
with RA was highlighted by the authors, so much so
that they question whether ankle arthritis in an early
oligoarthiritis setting should be seen as a negative
scoring variable for RA. In a Norwegian series of 138
patients with oligoarthritis, the ankle was involved in 60
patients (43%) with a final diagnosis of UA in 25 (42%),
reactive arthritis (ReA) in 18 (30%), and sarcoid in 15
(25%). Of all patients with oligoarthritis and a final diag-
nosis of UA or ReA, the ankle was involved in 40% and
39%, respectively [23]. In a series of 100 patients with
ReA from Kosovo [24], the most frequent presentation
was as an oligoarthritis. The ankle was the second
most commonly affected joint, involved in 55% of all
patients, higher in males (57.5% of 66 cases) than
females (50% of 34 cases). In a French series of 220
patients with acute oligo or polyarthritis <1 year dur-
ation, 64 ankle joints were involved, not stated whether
unilateral or bilateral, giving a prevalence between
14.5% and 29% [20].
Evaluation of joint distribution at RA presentation in
two early arthritis cohorts from the Netherlands (n¼947)
and India (n¼ 947) revealed the ankle to be recorded as
swollen in 5–15% of cases, slightly more so in autoanti-
body negative cases in the Netherlands [25]. In a large
series of 1000 RA patients from Sweden with estab-
lished RA, median duration 10 years, 17% recalled in-
volvement of the hindfoot/ankle at presentation [26]. In a
study of 102 patients with early RA of <1 year duration,
unilateral ankle involvement was reported in 23–25%, bi-
lateral in 18% [27]. In a series of early RA (n¼ 61) and
early PsA (n¼33) from UK and Italy, with <12 months
disease duration, ankle involvement was reported in
40% with RA and 27% with PsA [28].
Thus, in these series of 462 patients presenting with
incident oligo or polyarthritis, the ankle is reported to
be affected in 24–43% of all cases. As with incident
monoarthritis, the final diagnosis in those with persist-
ing arthropathy appears more likely to be SpA/ReA,
UA or sarcoidosis than RA or other conditions. In RA,
ankle involvement at presentation is less prevalent,
FIG. 1 Haemochromatosis arthropathy of the ankle
(A) Plain radiograph showing reduced tibio-talar joint space and marginal osteophyte formation. (B) T2 fat suppressed
MRI showing periarticular marrow oedema and multiple distal tibia and talar dome subchondral cysts.








atology/article/60/1/23/5937288 by guest on 19 February 2021
in series ranging from 5–25% with one exception
reporting 40%. The MRI appearances of sero-negative
undifferentiated inflammatory arthritis of the ankle are
shown in Fig. 2.
Established inflammatory arthritides
Axial spondyloarthritis
In a Brazilian series of 147 patients with established
ankylosing spondylitis [29], the ankles were the most fre-
quently involved extra-axial joints, affected in 39.5% of
cases, followed by hips (36.1%) and knees (29.3%).
Ankle involvement was significantly more frequent
among B27 positive cases (45.2% vs 18.8%) and in
those with juvenile vs adult onset AS, occurring in
63.6% vs 35.2% of cases, respectively.
Peripheral spondyloarthritis with psoriasis
In a UK series of 87 patients with established PsA, with
data available at two time points (baseline median dis-
ease duration 11 years, followed for a median
65 months) the prevalence of ankle arthritis was 10.3%
rising at follow up to 26.4% [30]. In a separate UK series
of 50 patients with established PsA, median disease
duration 19.5 years, the ankle was involved in 30–39%,
slightly less frequently in males and those without nail
disease [31]. In a second series from the same author of
77 patients with late PsA from UK and Italy, ankle in-
volvement was recorded in 38.5% [28].
Peripheral spondyloarthritis with inflammatory bowel
disease
In a population-based inception cohort of 160 patients
with IBD, mean disease duration 50 months, peripheral
arthritis was found in 17 cases (10.6%) with the knee and
ankle being the most frequently affected joints in 9/17,
53% [32]. In a large UK hospital series of 1459 patients
with IBD, median 10 years follow up, ankle joint arthrop-
athy was recorded in 29–34% with ulcerative colitis and
in 42–52% with Crohn’s disease, in the setting of pauci
and polyarticular patterns, respectively [33].
Thus, ankle involvement in established axial and per-
ipheral spondyloarthritis is common affecting up to 63%
of juvenile and 10–52% of adult cases, though the litera-
ture is remarkably sparse.
Rheumatoid arthritis
A study assessing the validity and reliability of joint
counts (28 vs 66/68 joints) using data from 735 patients
with established RA reports a prevalence of ankle joint
swelling and pain between 60% and 65% [34]. In a
Swedish cross-sectional clinic survey of 1000 RA
patients with median disease duration 10 years, 52%
had ankle or hindfoot disease [26]. In a series of late
RA (n¼93) from UK and Italy, ankle involvement was
reported in 65% [28], and in the UK Early RA Study
(ERAS) of 1237 patients, reduced ankle range of move-
ment was found in 37% ever, during up to 25 years fol-
low up [35]. From a postal questionnaire, returned by
585 UK RA patients with mean disease duration
12.7 years, 42.7% reported ankle pain at some stage in
the course of their RA, and 30.6% reported ankle pain
in the last month [36]. A Korean series of 2046 patients
with established RA found a prevalence of ankle ten-
derness in 21% and ankle swelling in 17% [37].
Thus, while ankle involvement is unusual at disease
onset in RA, it is reported in higher prevalence in estab-
lished RA, in the range 37–65% with a lower report from
Korea of 17–21%.
Connective tissue diseases
In SLE, arthralgia without evidence of synovitis is a com-
mon feature. In contrast, the typical non-erosive deform-
ing arthropathy of Jaccoud is not, with most series
indicating a prevalence <5%, focused mainly on the
hands [38, 39]. When foot problems have been
addressed, Jaccoud’s arthropathy of the feet has been
reported to rarely occur without hand involvement [40].
A postal survey of symptoms in 131 New Zealand SLE
patients reported the hind foot or ankle to have ever
been painful since SLE diagnosis in 30% and 32% of
respondents, and painful in the last month in 19% and
13%, without independent clinical assessment or ascer-
tainment of the relation to SLE itself as opposed to other
biomechanical factors [41].
In SSc, arthralgia is commoner than arthritis; however,
when synovitis occurs the MCP, PIP, wrists and ankles
predominate. In the hind foot, care should be taken to
distinguish ankle arthritis from tendon disease as ten-
donopathy, often with friction rubs, is a characteristic
feature of SSc and the tibialis anterior, peroneal and
Achilles tendons can all be affected [42].
FIG. 2 Sero-negative undifferentiated peripheral spondy-
loarthropathy of the ankle
Sagittal Short-T1 Inversion Recovery (STIR) MRI of the
left ankle showing joint capsule thickening, synovitis and
effusion of the tibio-talar joint extending into the poster-
ior joint recess.
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Septic arthritis
Bacterial infection
Bacterial sepsis can potentially affect any joint, though
certain joints are more frequently involved than others,
especially the knee, and the ankle is not exempt. In a
Dutch study of 186 patients with bacterial septic arth-
ritis, the ankle was the third most commonly affected
joint, reported in 12% of cases, after knee (48%) and
hip (21%) [43]. A prospective UK study of 75 patients
with bacterial septic arthritis also found the knee (56%)
and hip (16%) to be the most frequently affected joints,
whereas the ankle was only involved in 1% of cases
[44]. An example of the X-ray appearances of bacterial
septic arthritis of the ankle are shown in Fig. 3.
A report of 25 cases of polyarticular bacterial septic
arthritis, and review of 303 case reports in the literature,
found the ankle to be affected in 24% of 25 cases, less
frequently than the knee, elbow, shoulder, wrist and
MCP/PIP joints. From the literature review of 303 polyar-
ticular bacterial septic cases, the ankle was affected in
54 cases (18%) also less frequently than knee, elbow,
shoulder and wrist [45]. In gonococcal disease, an acute
oligoarthritic presentation including the ankle is recog-
nized [46].
Viral infection
Viral arthritides are often polyarticular, involving small
and large joints, non-erosive and transient [47]. The
ankles are notably reported to be involved in Hepatitis
B, C, chikungunya and HIV infections [47, 48]. A review
from the literature of 63 patients with Hepatitis B related
arthritis reports ankle involvement in 24% cases, the
third most frequently affected joint after the proximal
interphalangeal (82%) and knees (30%) [49]. In a pro-
spective Colombian cohort of 500 confirmed cases of
chikungunya infection, ankle pain was recorded in 87%,
being the second commonest site of joint pain after the
wrist [50]. In two series of patients with chikungunya
infection from India and Sri Lanka, the ankle was
reported to be a site of arthralgia at disease onset in
11.39% and 33.7% cases, respectively [51].
HIV-associated arthritis/painful articular syndrome can
occur at any stage of HIV illness, usually presenting as a
self-limiting asymmetric oligoarthritis predominantly
affecting knees, shoulders and ankles [52]. Of 21 cases
reported in one centre, over half presented with an oli-
goarthritis involving knees and ankles. HIV is also asso-
ciated with a high prevalence of peripheral SpA with
predominant lower limb involvement including a high
prevalence of ankle disease [52–54]. In a series of 27
HIV-positive patients presenting with PsA, the joint dis-
tribution at onset involved the knee and/or ankle in 90%
in the context of psoriasis with an asymmetric lower
limb dominant polyarthritis and enthesitis [55]. A series
of 18 cases of ReA in HIV-positive patients reported
ankle involvement in 27%, after knee (41%) and wrist
(29%) [54]. The same authors report ankle involvement
in 50% of nine cases of PsA in HIV-positive patients,
and ankle involvement in 20% of cases with undifferenti-
ated SpA and HIV.
Tuberculosis
Tuberculosis (TB) of the foot and ankle is rarely
described, accounting for 1–4% of all cases of osteoar-
ticular TB [56]. A series of 74 patients with TB of the
foot and ankle reported ankle involvement in 13 cases
(17%) with a similar frequency involving the midtarsal
and Lisfrancs joint [57].
Crystal arthritis
Gout is well known to have a predilection for affecting
the first MTP, and potentially any other joint in the body.
The ankle is frequently involved, with 50% of 354
patients with chronic gout reporting involvement of the
ankle/foot (not great toe) in a historic UK series [58].
This is supported by findings in a series of 164 UK
patients where the ankle is reported as the third most
FIG. 3 Septic arthritis of the ankle due to Staphylococcus aureus infection
Plain radiograph showing fuzziness of cortical margins of the distal tibia, fibula and both malleoli.
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frequently affected joint in acute gout, involving 12–15%
cases, after the first MTP and mid-foot [59] and the
most frequently affected joint, with the first MTP and
knee, in a series from West Africa [60]. A contemporary
review confirms the ankle as a frequent site of acute
gouty arthritis [61].
Calcium pyrophosphate arthropathy is often found in
the context of OA, irrespective of whether primary or
post traumatic/inflammatory in origin. The knee and
wrist are the most commonly affected joints [62], and al-
though the ankle can be involved [63], it is less often
cited, possibly reflecting the low prevalence of OA of
this joint.
Charcot arthropathy
Charcot neuropathic arthropathy affects people with
peripheral neuropathies and commonly affects the foot,
reported in 0.1–0.9% of people with diabetes [64]. The
mid foot is the most frequent site of pathology with
the ankle much less frequently involved, reported with
the subtalar joint in 10% of cases compared with tarso-
metatarsal 40% and navicular/cuboid in 30% [65].
Peri-articular swelling
As advances in medicine bring more investigations into
routine practice, the skill and value of clinical examin-
ation can be overshadowed in the diagnostic process
[66, 67]. The hind foot is a particularly complex anatom-
ical region where it can be difficult to distinguish ankle
arthritis from sub talar disease, the former assessed
with passive flexion and extension and the latter with in-
version and eversion. Many non-articular conditions may
also cause peri-articular swelling and/or a reduced
range of hind foot flexion and extension. This can be
due to periostosis, subcutaneous oedema, tender adi-
pose tissue, panniculitis, tendon or ligament injury and
dermatologic conditions such as cellulitis, lipodermato-
sclerosis and chronic leg ulcers (arthropathica ulcerosa)
[68]. Historical reports in the literature are confounded
by these clinical limitations. When necessary, ultrasound
and other imaging techniques can be used to confirm
the presence of ankle joint disease, as opposed to other
causes of hind foot swelling, alongside thorough clinical
examination and gait analysis, skills we risk losing [64].
Sarcoidosis
Acute sarcoid arthritis occurs in the context of Lofgren’s
syndrome, characterised classically in younger patients
(<40 years) by the triad of erythema nodosum, bilateral
hilar lymphadenopathy and migratory polyarthritis,
sometimes with fever. Involvement of the ankle in acute
sarcoid arthritis is almost universally reported [69].
However, this is a historical error of attribution, as the
hind foot swelling of Lofgren’s syndrome has been dem-
onstrated on ultrasound to be more frequently due to
deep subcutaneous oedema (panniculitis) or tenosyno-
vitis, with no abnormal features in the ankle joint. Three
ultrasound studies have demonstrated this in 100 cases,
with the majority not showing features of arthritis, in-
stead just small effusions in 25%, and increased vascu-
larity in only 5.6–7.5% [70–72]. MRI of five ankles from
four patients with Lofgren’s syndrome confirms this,
with swelling located to the subcutaneous fat (panniculi-
tis) and only small ankle joint effusions with no synovial
thickening [73]. Thus, the cause of hind foot swelling in
acute sarcoidosis due to Lofgren’s syndrome is princi-
pally not due to ankle arthritis and any joint involvement
is likely to be reactive. An example of the clinical and
MRI appearances of the hind foot in Lofgren’s syndrome
is shown in Fig. 4.
Chronic sarcoid arthritis is much less frequent than
Lofgren’s and also said to commonly affect the ankles
[69]. Reports in the literature are of mixed acute and
chronic cases, with many resolving, making the attribu-
tion of arthritis to the ankle as opposed to periarticular
panniculitis uncertain. Nevertheless, in one report of
chronic sarcoid arthritis, the ankle was involved in all
four cases [74], and it has been suggested that the
presence of real ankle arthritis in Lofgren’s syndrome
is a risk factor for the development of chronic
arthritis [72].
Hypertrophic pulmonary osteoarthropathy
Hypertrophic osteoarthropathy is characterised by a
triad of digital clubbing, periosteal reaction of long
bones (periostosis) and pain or tenderness of the limbs,
sometimes with non-inflammatory effusions of large
joints [75]. The distal tibia and fibula are frequently
involved, and radionuclide bone scan is the most sensi-
tive imaging modality to detect this pathology. Multiple
case series involving the hind feet are reported in the lit-
erature, some with ankle joint effusions mimicking react-
ive or other inflammatory arthritides [75, 76].
Tibialis posterior tendon dysfunction
This is a common cause of hind foot pain and swelling,
particularly prevalent in women over 40 years. It may
present with diffuse hind foot swelling and maximal ten-
derness posterior and inferior to the medial malleolus,
along the course of the tendon [77]. Chronic cases are
invariably associated with hindfoot valgus deformity and
flatfoot, which can be easily appreciated by gait ana-
lysis, with visual inspection of the hind foot from behind.
Conclusions
This review has highlighted the diagnostic implications
of ankle joint arthropathy across the spectrum of clinical
rheumatologic practice, revealing this joint to be a useful
signpost. It is structurally interesting, having evolved
much later than the knee, with significant differences in
cartilage properties and response to inflammatory cyto-
kines. These properties may make the ankle less sus-
ceptible to the pathologic processes leading to some
arthropathies; notably, rarely developing OA in the
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FIG. 4 Lofgren’s syndrome clinical and MRI inversion recovery images
Images show (A) lateral, (B) midline and (C) medial sagittal sections of the hind foot with extensive subcutaneous en-
hancement (arrows) and no ankle joint disease.
TABLE 1 Prevalence of ankle arthritis in rheumatic diseases in individual case series
Condition Prevalence of ankle involvement Number of patients, number
with ankle involvement
Author (reference)
Early RA 15% 1894, 284 Bergstra 2017 [25]
17% 1000, 170 Grondal 2008 [26]
25% 102, 25 Fleming 1976 [27]
40% 61, 24 Helliwell 2000 [28]
Combined total 16.4% 3057, 503
Established RA 65% 735, 478 Smolen 1995 [34]
52% 1000, 520 Grondal 2008 [26]
37% 1237, 458 Backhouse 2011 [35]
65% 93, 60 Helliwell 2000 [28]
17% 2046, 348 Lee 2019 [37]
Combined total 36% 5129, 1864
Early PsA 27% 33 Helliwell 2000 [28]
Early ReA 55% 100, 55 Lahu 2015 [24]
39% 46, 18 Kvien 1996 [23]
Combined total 50% 146, 73
Established PsA 39% 50, 19 Helliwell 1991 [31]
38.5% 77, 30 Helliwell 2000 [28]
26% 87, 22 McHugh 2003 [30]
Combined total 33% 214, 71
Established AS 39.5% 147 Sampaio-Barros 2001 [29]
Septic arthritis 18% 303, 55 Dubost 1993 [45]
12% 186, 22 Kaandorp 1997 [43]
1% 75, 1 Gupta 2001 [44]
Combined total 14% 564, 78
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absence of trauma, and less commonly involved in early
RA than peripheral SpA.
A summary of the information we have gathered is
presented in Table 1, and Supplementary Table S1,
available at Rheumatology online, and we propose an
algorithm to help the diagnostic process (Fig. 5). As a
signpost, the finding of OA of the ankle should prompt
careful evaluation. If a traumatic cause cannot be
established, and primary OA seems likely, this should
be recognised as a rarity and trigger a search for other
conditions, especially haemochromatosis. Ankle in-
volvement in incident inflammatory arthritis is also a
signpost. If it is a monoarticular presentation, then a
crystal explanation points to gout rather than CPPD
disease. In septic causes, ankle disease points to bac-
terial including gonococcus but not TB, and of the
autoimmune arthropathies to UA or peripheral SpA ra-
ther than RA or CTD as a final diagnosis. If the presen-
tation is acute oligo or polyarthritis then, as in
monoarthritis, ankle disease points to UA or peripheral
SpA rather than RA or CTD, and of septic causes to
bacterial including gonococcal and viruses including
chikungunya and HIV. Why the ankle is more likely to
be affected early in peripheral SpA as opposed to RA
or CTD arthropathies is unclear, but a useful clinical
observation and signpost.
In established inflammatory arthritis, involvement of
the ankle is more universal, with a similar prevalence in
RA as axial and peripheral SpA and so in this context
the presence of ankle disease is of less value to the
diagnostic process.
A limitation of this article is that there are surprisingly
few reports in the literature of individual joint distribution
and prevalence in various rheumatic diseases. This is
not a formal systematic review and some published
data may have been overlooked. Many descriptions of
classic arthropathies combine joint regions (e.g. ‘foot’,
or ‘knee and ankle’) or report overall prevalence of per-
ipheral arthropathy rather than providing individual joint
level data. Furthermore, difficulties in clinical assessment
before the introduction of US and MRI make it likely that
some historical reports of ankle arthritis were inaccurate
if the pathology was not distinguishable from peri-
articular causes of pain or swelling. Lofgren’s syndrome
exemplifies this, with ankle arthritis enshrined in medical
literature as a classic feature, whereas US and MRI re-
veal that the cause of hind foot swelling is usually deep
subcutaneous oedema and only rarely ankle arthritis.
The time has come for textbooks to be re-written in this
instance.
With the advent of artificial intelligence and its appli-
cation to diagnostic medicine, it would be useful for new
detailed reports of individual joint prevalence to be
documented at various stages of rheumatic and muscu-
loskeletal diseases. Accurate documentation of clinical
signs can provide essential ‘big data’ to inform com-
puter algorithms to support diagnosis, and enable sub
group classification. This has been applied to juvenile
idiopathic arthritis, where detailed assessment of every
joint resulted in the ability to model disease course and
outcome based on seven presenting patterns of joint in-
volvement [78].
Thorough clinical assessment, aided by imaging
where necessary, remains central to good quality clinical
practice. A potential weakness of telemedicine, which
has become a necessity in the COVID-19 pandemic, will
be an emphasis on imaging and laboratory assessments
over examination findings [67, 68]. Furthermore, en-
shrinement of 28 joint counts in DAS28, Clinical Disease
Activity Index (CDAI) and Simple Disease Activity Index
(SDAI) composite scores in RA management contrib-
utes to a loss of emphasis on assessment of the distal
lower limb in the mindset of the clinician. However, the
recognition of clinical patterns is fundamental to mak-
ing a diagnosis and the presence of ankle arthritis is
especially valuable. The relative protection of the ankle
from OA compared with the knee and hip, and its
differential involvement in the auto-immune arthritides
remain intriguing and under-investigated research
questions. We believe the ankle joint is a useful sign-
post to differential diagnosis in clinical rheumatologic
practice, and we should be encouraged to pay it par-
ticular attention.
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